Gotowa bibliografia na temat „Lung and breast/ovarian cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Lung and breast/ovarian cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Lung and breast/ovarian cancer"
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero i Javier Cortes. "Molecular identification of basal-like breast cancer through genomic analyses across five cancer types." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Pełny tekst źródłaAchariyapota, Vuthinun, Tuenjai Chuangsuwanich i Mongkol Benjapibal. "Inflammatory Breast Cancer from Metastatic Ovarian Cancer". Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Pełny tekst źródłaR., Abhirup H., Priyanka Kenchetty i Aishwarya K. Chidananda. "Breast ovarian cancer syndrome". International Surgery Journal 8, nr 8 (28.07.2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Pełny tekst źródłaAbu-Tineh, Mohammad, Hind Elmalik i Mohamed A. Yassin. "Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report". Case Reports in Oncology 13, nr 2 (28.07.2020): 867–74. http://dx.doi.org/10.1159/000508358.
Pełny tekst źródłaBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu i Iulian Brezean. "Breast metastases from ovarian cancer". Romanian Medical Journal 69, S4 (20.06.2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Pełny tekst źródłaArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law i Gillian E. Hanley. "Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada". International Journal of Gynecologic Cancer 29, nr 3 (21.12.2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Pełny tekst źródłaHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni i in. "Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Pełny tekst źródłaTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue i Ginette Serrero. "Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies". Cancer Research 83, nr 8_Supplement (14.04.2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Pełny tekst źródłaRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick i Nshimirimana Eric. "Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report". International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, nr 10 (23.09.2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Pełny tekst źródłaYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks i in. "Development of a Multimarker Assay for Early Detection of Ovarian Cancer". Journal of Clinical Oncology 28, nr 13 (1.05.2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Pełny tekst źródłaRozprawy doktorskie na temat "Lung and breast/ovarian cancer"
Woods, Tonya M. "Extracting meaningful statistics for the characterization and classification of biological, medical, and financial data". Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/53857.
Pełny tekst źródłaDucrot, Lucas. "Réseaux bayésiens et analyse de survie pour l’estimation de courbes de pénétrance du cancer broncho-pulmonaire lié à des prédispositions génétiques". Electronic Thesis or Diss., Sorbonne université, 2024. http://www.theses.fr/2024SORUS055.
Pełny tekst źródłaThis thesis focuses on estimating penetrance curves of genetic diseases from pedigree data, with a particular interest in the genetic predisposition to bronchopulmonary cancer. In this context, it aims to provide clinical and epidemiological results, as well as methodological findings.Genetic counselling is offered to patients with severe family histories of genetic diseases. Geneticists must select from these patients who should be offered genetic testing, and assess the disease risks for these patients and their families. Advances in genetics are rapid, and the number of identified pathogenic variants for different diseases increases each year. This necessitates significant predictive and risk assessment tools, especially in the context of bronchopulmonary cancer. Indeed , the links between the latter and pathogenic variants (such that SFTPA1/SFTPA2 and the genes TP53 and EGFR) are known but still poorly described.Existing methods for assessing the risk of disease occurrence rely on penetrance curves, but their estimation faces challenges due to the small number of patients and the omnipresent selection bias in genetics-collected datasets. To overcome these obstacles, the thesis explores the use of familial data, employing a set of statistical tools including Bayesian networks, mixture models, survival analysis, as well as existing models, for which it attempts to weaken certain assumptions.Chapter 1 provides an overview of the medical context of the thesis, introducing the concepts of genetic diseases and genetic counseling. Chapter 2 serves as a methodological introduction, presenting and illustrating concepts such as survival analysis, Bayesian networks, sum-product algorithm, mixture models and EM algorithm, using examples. It also offers a state-of-the-art review of penetrance curve estimation for genetic diseases and highlights the selection bias in genetics. The chapter concludes with a summary of the addressed research questions.Then, the thesis revolves around four projects. The first two projects, corresponding to chapters 3 and 4, offer predominantly clinical and epidemiological results. The first project, described in Chapter 3, compares different methods for predicting pathogenic variants for breast/ovarian cancers (Manchester Score and family models like BOADICEA). The second project, addressed in Chapter 4, provides estimates of penetrance for interstitial lung disease and bronchopulmonary cancer for carriers of pathogenic variants SFTPA1 and SFTPA2.The last two projects, corresponding to chapters 5 and 6, are more methodological. Chapter 5 is dedicated to developing a new method for estimating the penetrance curve of a genetic disease from pedigree data when the disease presents sporadic cases. It is based on an incidence constraint of the disease in the general population and a parameterization of the relative hazard between carriers and non-carriers of pathogenic variants. Chapter 6 focuses on highlighting the bias introduced by selection in genetics and its consequences on the results of the method developed in Chapter 5. Known correction methods, such as Proband's Phenotype Exclusion Likelihood (PEL) and Genotype-Restricted Likelihood (GRL), combined with our method, are applied to simulated data
Vehmanen, Paula. "Breast cancer-predisposing genes in Finnish breast and ovarian cancer families". Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/vehmanen/.
Pełny tekst źródłaFord, Deborah. "Genetic epidemiology of breast and ovarian cancer". Thesis, Institute of Cancer Research (University Of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367527.
Pełny tekst źródłaSchofield, Andrew C. "Molecular genetics of breast and ovarian cancer". Thesis, University of Aberdeen, 1998. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU100481.
Pełny tekst źródłaHuusko, P. (Pia). "Predisposing genes in hereditary breast and ovarian cancer". Doctoral thesis, University of Oulu, 1999. http://urn.fi/urn:isbn:9514254422.
Pełny tekst źródłaXintaropoulou, Chrysi. "Targeting aerobic glycolysis in breast and ovarian cancer". Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/29525.
Pełny tekst źródłaCheng, Wing-ming Edward. "Emotional well-being in Chinese lung cancer patients". Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3197157X.
Pełny tekst źródłaHarbord, Sara Helen Alison. "X chromosome studies and breast and ovarian carcinoma". Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/212.
Pełny tekst źródłaBendrik, Christina. "Angiogenesis regulation in hormone dependent breast- and ovarian cancer". Doctoral thesis, Linköpings universitet, Institutionen för klinisk och experimentell medicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63745.
Pełny tekst źródłaKsiążki na temat "Lung and breast/ovarian cancer"
Cancer sourcebook for women: Basic consumer health information about gynecologic cancers and other cancers of special concern to women, including cancers of the breast, cervix, colon, lung, ovaries, thyroid, and uterus; along with facts about benign conditions of the female reproductive system, cancer risk factors, screening and prevention programs, women's issues in cancer treatment ... Wyd. 4. Detroit, MI: Omnigraphics, 2010.
Znajdź pełny tekst źródłaNakamura, Seigo, Daisuke Aoki i Yoshio Miki, red. Hereditary Breast and Ovarian Cancer. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1.
Pełny tekst źródłaPaula, Dranov, red. Breast cancer and ovarian cancer: Beating the odds. Reading, Mass: Addison-Wesley, 1992.
Znajdź pełny tekst źródłaAoki, Daisuke, Seigo Nakamura i Yoshio Miki, red. Practical Guide to Hereditary Breast and Ovarian Cancer. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-5231-1.
Pełny tekst źródła1963-, Morrison Patrick J., Hodgson S. V i Haites Neva E. 1947-, red. Familial breast and ovarian cancer: Genetics, screening, and management. Cambridge, UK: Cambridge University Press, 2002.
Znajdź pełny tekst źródła1963-, Morrison Patrick J., Hodgson S. V i Haites Neva E. 1947-, red. Familial breast and ovarian cancer: Genetics, screening, and management. Cambridge: Cambridge University Press, 2005.
Znajdź pełny tekst źródła1940-, Hayat M. A., red. Lung and breast carcinomas. Amsterdam: Elsevier, Academic Press, 2008.
Znajdź pełny tekst źródłaLange, Vladimir. Be a survivor: Lung cancer treatment guide. Wyd. 2. Los Angeles, CA: Lange Productions, 2012.
Znajdź pełny tekst źródłaHartikainen, Jaana. Genetic predispossition to breast and ovarian cancer in Eastern Finnish population. Kuopio: University of Kuopio, 2007.
Znajdź pełny tekst źródłaGenetic testing for breast and ovarian cancer risk: It's your choice. Wyd. 2. Bethesda, Md.]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute, 2005.
Znajdź pełny tekst źródłaCzęści książek na temat "Lung and breast/ovarian cancer"
Workman, Paul. "Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective". W Advances in Experimental Medicine and Biology, 163–79. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40204-4_11.
Pełny tekst źródłaMasuda, Kenta, Megumi Satake i Daisuke Aoki. "Hereditary Ovarian Cancer". W Hereditary Breast and Ovarian Cancer, 93–106. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_7.
Pełny tekst źródłaClarke, Angus. "Breast and ovarian cancer". W Harper's Practical Genetic Counselling, 415–20. Eighth edition | Boca Raton : CRC Press, [2020] | Preceded by Practical genetic counselling / Peter S. Harper. 7th ed. 2010.: CRC Press, 2019. http://dx.doi.org/10.1201/9780367371944-31.
Pełny tekst źródłaMiyashita, Minoru, i Takanori Ishida. "Hereditary Breast Cancer". W Hereditary Breast and Ovarian Cancer, 79–92. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_6.
Pełny tekst źródłaKobayashi, Hiroshi. "Chemoprevention for Ovarian Cancer". W Hereditary Breast and Ovarian Cancer, 149–67. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_10.
Pełny tekst źródłaWatanuki, Rurina, Aiko Nagayama, Tetsu Hayashida i Yuko Kitagawa. "Chemoprevention for Breast Cancer". W Hereditary Breast and Ovarian Cancer, 129–48. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_9.
Pełny tekst źródłaBlack, D. M., i E. Solomon. "The BRCA1 gene in sporadic breast and ovarian cancer". W Ovarian Cancer 3, 39–44. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4757-0136-4_4.
Pełny tekst źródłaLux, Michael P., Mayada R. Bani, Peter A. Fasching i Matthias W. Beckmann. "Hereditary Breast and Ovarian Cancer". W The Molecular Basis of Human Cancer, 401–21. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-59745-458-2_26.
Pełny tekst źródłaMurakami, Wakana, Mitsuhiro Tozaki, Kelly E. McCann i Stephanie Lee-Felker. "Risk-Based Breast Cancer Screening". W Hereditary Breast and Ovarian Cancer, 107–28. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_8.
Pełny tekst źródłaInuzuka, Mayuko. "Genetic Counseling in Hereditary Breast and Ovarian Cancer". W Hereditary Breast and Ovarian Cancer, 65–77. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4521-1_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Lung and breast/ovarian cancer"
Lemos, Nathalia Oliveira, Fábio Bagnoli, Maria Antonieta Longo Galvão Silva, José Francisco Rinaldi i Vilmar Marques de Oliveira. "INVASIVE LOBULAR BREAST CANCER METASTATIC TO THE ORBIT: A CASE REPORT". W XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1048.
Pełny tekst źródłaNguyen, Dat, Larry Rubinstein, Mark E. Sherman, Joseph E. Tomaszewski, Naoko Takebe, Percy Ivy, James H. Doroshow i Sherry X. Yang. "Abstract 3838: Differential expression of Notch1 in lung, ovarian and breast cancers". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3838.
Pełny tekst źródłaGEVAERT, O., S. VAN VOOREN i B. DE MOOR. "INTEGRATION OF MICROARRAY AND TEXTUAL DATA IMPROVES THE PROGNOSIS PREDICTION OF BREAST, LUNG AND OVARIAN CANCER PATIENTS". W Proceedings of the Pacific Symposium. WORLD SCIENTIFIC, 2007. http://dx.doi.org/10.1142/9789812776136_0028.
Pełny tekst źródłaGansmo, Liv B., Merete Bjørnslett, Anne Dørum, Helga Salvesen, Pål Romundstad, Kristian Hveem, Lars Vatten, Per Eystein Lønning i Stian Knappskog. "Abstract 4613: MDM4 SNP 34091 (rs4245739) effect on risk of breast, colon, lung, prostate, endometrial and ovarian cancer". W Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4613.
Pełny tekst źródłaHalim, Abdel-baset, Lisa M. Dauffenbach, Christopher A. Kerfoot, William R. Stull, Esther Zwick-Wallasch, Richard Scheyer i Giorgio Senaldi. "Abstract 3148: Immunohistochemical analysis of HB-EGF expression in breast, colon, gastric, hepatocellular, lung, ovarian, pancreatic and prostate cancer". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3148.
Pełny tekst źródłaFredolini, Claudia, Davide Tamburro, Santosh Goud, Chandler King, Weidong Zhou, Paul Russo, Virginia Espina i in. "Abstract 4787: Novel upfront sample enrichment nanotechnology identifies prostate, breast, colon, ovarian, lung, pancreatic, and melanoma cancer specific biomarker candidates". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4787.
Pełny tekst źródłaPirie-Shepherd, Steven R., Iman Jilani, Eric Tucker, David Valenta, Ryon Graf, Amanda Anderson, Dena Marrinucci, Puja Sapra i Eric L. Powell. "Abstract 565: Circulating tumor cell (CTC) detection and 5T4 characterization in breast, ovarian, and lung cancer patients on active therapy". W Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-565.
Pełny tekst źródłaOmofuma, Omonefe O., David P. Turner, Lindsay L. Peterson, Anwar T. Merchant, Jiajia Zhang i Susan E. Steck. "Abstract C033: Dietary advanced glycation end products (dAGEs) and breast cancer by race in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO)". W Abstracts: Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 20-23, 2019; San Francisco, CA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp19-c033.
Pełny tekst źródłaBorges, Isabella Sabião, João Victor Aguiar Moreira, Eustaquio Costa Damasceno Junior, Alencar Pereira dos Santos, Gabriela Tomás Alves, Leonardo Peixoto Garcia, Maria Fernanda Prado Rosa i in. "Chronic inflammatory demyelinating polyradiculoneuropathy induced by paclitaxel". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.413.
Pełny tekst źródłaLiu, H., i S. Muralitharan. "A Survey of NY-BR-1 Immunohistochemistry in Breast, Ovarian, Endometrial and Lung Cancers: A Correlation Study with Estrogen and Progesterone Receptors." W Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-6018.
Pełny tekst źródłaRaporty organizacyjne na temat "Lung and breast/ovarian cancer"
Tennis, Meredith A., i Peter G. Shields. Gene Environment Interactions in Women with Breast Cancer and Secondary Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2004. http://dx.doi.org/10.21236/ada428946.
Pełny tekst źródłaTennis, Meredith A., i Peter G. Shields. Gene Environment Interactions in Women With Breast and Secondary Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2005. http://dx.doi.org/10.21236/ada456364.
Pełny tekst źródłaBoushey, Carol, Jamy Ard, Lydia Bazzano, Steven Heymsfield, Elizabeth Mayer-Davis, Joan Sabaté, Linda Snetselaar i in. Dietary Patterns and Breast, Colorectal, Lung, and Prostate Cancer: A Systematic Review. U.S. Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Nutrition Evidence Systematic Review, lipiec 2020. http://dx.doi.org/10.52570/nesr.dgac2020.sr0104.
Pełny tekst źródłaFrost, Marlene H., Charles Loprinzi, Ann Kearns, Jeff Sloan i Debra Barton. Changes in Ovarian Stromal Function in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2005. http://dx.doi.org/10.21236/ada446278.
Pełny tekst źródłaBarton, Debra, Jeff Sloan, Charles Loprinzi i Ann Kearns. Changes in Ovarian Stromal Function in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2004. http://dx.doi.org/10.21236/ada428981.
Pełny tekst źródłaGoldgar, David E. Identification and Genetic Mapping of Genes for Hereditary Breast Cancer and Ovarian Cancer in Families Unlinked to BRCA1. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 1995. http://dx.doi.org/10.21236/ada301314.
Pełny tekst źródłaNeuhausen, Susan L. Identification and Genetic Mapping of Genes for Hereditary Breast Cancer and Ovarian Cancer in Families Unlinked to BRCA1. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 1999. http://dx.doi.org/10.21236/ada382834.
Pełny tekst źródłaFrost, Marlene H. Changes in Ovarian Stromal Function and Associated Symptoms in Premenopausal Women Undergoing Chemotherapy for Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2008. http://dx.doi.org/10.21236/ada510068.
Pełny tekst źródłaWang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang i in. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.
Pełny tekst źródłaBattaglia, Tracy, Christine Gunn, Sharon Bak, JoHanna Flacks, Kerrie Nelson, Na Wang, Naomi Ko i Samantha Morton. Reducing Legal Barriers to Help Patients Receive Treatment for Breast and Lung Cancer—The Project SUPPORT Study. Patient-Centered Outcomes Research Institute (PCORI), lipiec 2020. http://dx.doi.org/10.25302/07.2020.ad.13046272.
Pełny tekst źródła